C1-Esterase Inhibitor (Recombinant) and Incruse Ellipta
Determining the interaction of C1-Esterase Inhibitor (Recombinant) and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1-Esterase Inhibitor (Recombinant)-Indacaterol
- C1-Esterase Inhibitor (Recombinant)-Indacaterol and Glycopyrrolate
- C1-Esterase Inhibitor (Recombinant)-Indacaterol and glycopyrrolate Inhalation
- C1-Esterase Inhibitor (Recombinant)-Indacaterol inhalation
- C1-Esterase Inhibitor (Recombinant)-Indacaterol Maleate
- C1-Esterase Inhibitor (Recombinant)-Indapamide
- Incruse Ellipta-Cabazitaxel
- Incruse Ellipta-Cabazitaxel Intravenous
- Incruse Ellipta-Cabergoline
- Incruse Ellipta-Cablivi
- Incruse Ellipta-Cabometyx
- Incruse Ellipta-Cabozantinib